NEXT Pharmaceuticals, a world-renowned biotech company, is facing a serious governance crisis as an internal power struggle within its board of directors has erupted into public view. The conflict among the company’s top executives has drawn widespread attention from investors, employees, and regulators, revealing deeper structural issues in corporate governance. The turmoil has already impacted...